ABILIFY MAINTENA (Otsuka America Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the ABILIFY MAINTENA drug offered from Otsuka America Pharmaceutical, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Otsuka America Pharmaceutical, Inc. |
| NON-PROPRIETARY NAME: | aripiprazole |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-02-28 |
| END MARKETING DATE: | 0000-00-00 |
ABILIFY MAINTENA HUMAN PRESCRIPTION DRUG Details:
| Item Description | ABILIFY MAINTENA from Otsuka America Pharmaceutical, Inc. |
| LABELER NAME: | Otsuka America Pharmaceutical, Inc. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2013-02-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59148-018_3687d391-4e13-4449-ba3b-a92d99201e99 |
| PRODUCT NDC: | 59148-018 |
| APPLICATION NUMBER: | NDA202971 |